Methods for use of a specific anti-angiogenic adenoviral agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9567605
APP PUB NO 20140010785A1
SERIAL NO

13520457

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-angiogenic adenovirus vectors, and therapeutic use thereof are provided, and more particularly, but not exclusively, clinical protocols for treatment of solid tumors in patients with an Ad5-PPE-1-3X-fas-chimera adenovirus vector.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VASCULAR BIOGENICS LTDMODIIN 7178106

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bangio, Livnat Petach-Tikva, IL 18 229
Breitbart, Eyal Hashmonaim, IL 57 528
Cohen, Yael Kiryat-Ono, IL 20 217
Feige, Erez Hemed, IL 15 96
Sher, Naamit Rechovot, IL 13 100

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 14, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00